ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $23,000 | -28.1% | 24,358 | +3.2% | 0.00% | – |
Q2 2023 | $32,000 | -97.4% | 23,593 | -28.0% | 0.00% | -100.0% |
Q3 2020 | $1,217,000 | +12.8% | 32,753 | +51.9% | 0.01% | 0.0% |
Q2 2020 | $1,079,000 | +58.7% | 21,568 | -10.1% | 0.01% | +50.0% |
Q1 2020 | $680,000 | -50.9% | 23,993 | -2.7% | 0.00% | -50.0% |
Q4 2019 | $1,386,000 | +80.2% | 24,668 | +9.4% | 0.01% | +100.0% |
Q3 2019 | $769,000 | -41.0% | 22,549 | -19.8% | 0.00% | -50.0% |
Q2 2019 | $1,304,000 | +69.4% | 28,115 | +46.5% | 0.01% | +60.0% |
Q1 2019 | $770,000 | -6.7% | 19,189 | +6.8% | 0.01% | -16.7% |
Q4 2018 | $825,000 | +6.0% | 17,961 | +2.3% | 0.01% | 0.0% |
Q3 2018 | $778,000 | – | 17,550 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |